What are the dosages of Monocef (ceftriaxone) and Amoxiclav (amoxicillin/clavulanic acid) for adults and children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Dosages of Monocef (Ceftriaxone) and Amoxiclav (Amoxicillin/Clavulanic Acid) for Adults and Children

For optimal clinical outcomes, ceftriaxone (Monocef) should be dosed at 1-2 grams IV/IM once daily for adults and 50-100 mg/kg/day for children, while amoxicillin/clavulanic acid (Amoxiclav) should be dosed at 875/125 mg twice daily for adults and 40-90 mg/kg/day (of amoxicillin component) divided into 2-3 doses for children.

Ceftriaxone (Monocef) Dosing

Adult Dosing

  • Standard dose: 1-2 grams IV/IM once daily 1
  • Maximum dose: 4 grams per day 2
  • Duration: Generally 4-14 days, continue for at least 2 days after signs and symptoms of infection have disappeared 2

Pediatric Dosing

  • Standard infections: 50-75 mg/kg/day IV/IM once daily or divided twice daily 2
  • Maximum dose: 2 grams per day for standard infections 2
  • Severe infections/meningitis: 100 mg/kg/day (not to exceed 4 grams daily) 2
  • Specific indications:
    • Acute otitis media: Single IM dose of 50 mg/kg (not to exceed 1 gram) 3, 4
    • Skin and soft tissue infections: 50-75 mg/kg/day once daily or divided twice daily 2, 5

Special Considerations

  • Neonates: Contraindicated in premature neonates; in term neonates, administer IV doses over 60 minutes to reduce risk of bilirubin encephalopathy 2
  • Renal/Hepatic impairment: No dosage adjustment necessary unless severe impairment 2
  • Elderly: No modification required up to 2 grams per day in absence of severe renal/hepatic impairment 2

Amoxicillin/Clavulanic Acid (Amoxiclav) Dosing

Adult Dosing

  • Standard formulation: 500/125 mg orally three times daily
  • Extended-release formulation: 875/125 mg orally twice daily
  • Maximum daily dose: 4000 mg amoxicillin component

Pediatric Dosing

  • Standard infections: 40 mg/kg/day of amoxicillin component divided into 2-3 doses 3
  • Severe infections: 90 mg/kg/day of amoxicillin component divided into 2-3 doses
  • Specific indications:
    • Acute otitis media: 80 mg/kg/day of amoxicillin component with 10 mg/kg/day of clavulanate in three divided doses 4

Administration Guidelines

Ceftriaxone (Monocef)

  • IV administration: Infuse over 30 minutes (60 minutes in neonates) 2
  • IM administration: Inject well within a large muscle; reconstitute with appropriate diluent 2
  • Compatibility: Do not use diluents containing calcium; compatible with metronidazole 2

Amoxicillin/Clavulanic Acid (Amoxiclav)

  • Administer with food to enhance absorption and reduce GI side effects
  • Extended-release tablets should be swallowed whole, not crushed or chewed

Clinical Pearls and Pitfalls

  1. Pharmacokinetic advantages of ceftriaxone: Long half-life (7-8 hours) allows once-daily dosing in adults and children, providing sustained plasma concentrations above MICs for most pathogens for 24 hours 6, 7

  2. Common pitfalls to avoid:

    • Do not administer ceftriaxone with calcium-containing solutions, especially in neonates 2
    • Do not use amoxicillin/clavulanic acid in patients with history of penicillin allergy
    • Avoid underdosing amoxicillin/clavulanic acid in areas with high prevalence of resistant organisms
  3. Efficacy considerations:

    • Ceftriaxone 2g once daily is as effective as more frequent dosing regimens of other cephalosporins for serious bacterial infections 8
    • Single-dose ceftriaxone (50 mg/kg) has comparable efficacy to 10-day amoxicillin/clavulanic acid for pediatric acute otitis media 4

Always consider local antimicrobial resistance patterns and adjust therapy accordingly. Monitor for clinical improvement within 48-72 hours and consider de-escalation to oral therapy when appropriate.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.